A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To evaluate the efficacy and safety of ART-123 on sensory symptoms of oxaliplatin-induced peripheral neuropathy (OIPN) in patients with unresectable metastatic colorectal cancer who receive oxaliplatin-containing chemotherapy
Epistemonikos ID: 715e937f6247aef85e5b6a35e7ae0270fd0f8703
First added on: May 07, 2024